Nagulesparen M, Ang V, Jenkins J S
Clin Endocrinol (Oxf). 1978 Jul;9(1):73-9. doi: 10.1111/j.1365-2265.1978.tb03574.x.
Plasma prolactin concentrations were measured in thirty-four males with pituitary tumours and twenty-two patients (65%) were found to have hyperprolactinaemia. Plasma testosterone concentrations were subnormal in twenty-nine patients. Ten patients with hyperprolactinaemia were treated with bromocriptine; prolactin was restored to normal values in eight patients but testosterone secretion remained deficient. Two patients were resistant to bromocriptine. Some improvement in libido and potency was obtained after restoration of normal prolactin concentrations in four cases in spite of persistently low testosterone secretion. For maximal improvement in sexual function treatment with both bromocriptine and testosterone was required.
对34名患有垂体瘤的男性患者测量了血浆催乳素浓度,发现22名患者(65%)有高催乳素血症。29名患者的血浆睾酮浓度低于正常水平。10名高催乳素血症患者接受了溴隐亭治疗;8名患者的催乳素恢复到正常水平,但睾酮分泌仍不足。2名患者对溴隐亭耐药。尽管睾酮分泌持续偏低,但4例患者催乳素浓度恢复正常后,性欲和性功能有了一定改善。为了使性功能得到最大程度改善,需要同时使用溴隐亭和睾酮进行治疗。